Abrisqueta, Pau
Loscertales, Javier
Terol, Maria José
Ramírez Payer, Ángel
Ortiz, Macarena
Pérez, Inmaculada
Cuellar-García, Carolina
Fernández de la Mata, Margarita
Rodríguez, Alicia
Lario, Ana
Delgado, Julio
Godoy, Ana
Arguiñano Pérez, José Mª
Berruezo, Mª José
Oliveira, Ana
Hernández-Rivas, José-Ángel
García Malo, Maria Dolores
Medina, Ángeles
García Martin, Paloma
Osorio, Santiago
Baltasar, Patricia
Fernández-Zarzoso, Miguel
Marco, Fernando
Vidal Manceñido, Mª Jesús
Smucler Simonovich, Alicia
López Rubio, Montserrat
Jarque, Isidro
Suarez, Alexia
Fernández Álvarez, Rubén
Lancharro Anchel, Aima
Ríos, Eduardo
Losada Castillo, María del Carmen
Pérez Persona, Ernesto
García Muñoz, Ricardo
Ramos, Rafael
Yáñez, Lucrecia
Bello, José Luis
Loriente, Cristina
Acha, Daniel
Villanueva, Miguel
This article is maintained by: Elsevier
Article Title: Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)
Journal Title: Clinical Lymphoma Myeloma and Leukemia
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clml.2021.07.022
Content Type: article
Copyright: © 2021 The Author(s). Published by Elsevier Inc.